By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
I am very excited to announce that Life Science Nation (LSN) and Life Science Incubation Council (LSIC) has signed a MoU to work together to support the life science ecosystem in Japan!
Established in 2022, Life Science Incubation Council is a Japanese organization that has created a platform on which key players in the sector such as start-ups, VCs, pharmaceutical companies, medical device companies and government organizations can work together to develop innovative technology seeds, aiming towards commercialization of these technologies. LSIC and LSN signed a MoU to work together for the development of the Japanese life science industry on a global scale.
On Wednesday, March 27, 7:00 – 8:30pm EST / Thursday, March 28, 8:00 – 9:30am JST, LSN and LSIC will be organizing a 90-minute webinar including an introduction of LSN’s platform and our value-add for the global life science ecosystem, remarks from panelists who are familiar with LSN and have leveraged our platform, and pitches from companies developing innovative therapeutics. We expect over 150 people in attendance, including startups, investors, pharmaceuticals, and more. The webinar will be held in English, and everyone is welcome to join.
Please find our program below.
| Time (JST) | Topic | Speakers |
| 8:00 – 8:05 | Opening Remarks |
|
| 8:05 – 8:35 | Introduction of LSN (30 minutes) |
|
| 8:35 – 9:00 | Success Stories and Experiences from LSN Network (25 minutes) |
|
| 9:00 – 9:25 | Innovative Drug Pipelines of LSN Clients (25 minutes) |
|
| 9:25 – 9:30 | Q&A / Closing Remarks |










Leave a comment